Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale ...

注目を浴びたRNA配列解読研究に、統計学的な欠陥があると異議が。 ここ数年間、ハイスループットRNAシーケンシング技術によって、いくつかの予想もしなかった結果がもたらされた。この中には遺伝学の一般通念を書き換えるようなものもある。しかし ...

Researchers at Japanese universities discovered that two neighboring genes, old and zao, regulate antiviral responses and symptom expression in the fungus Neurospora crassa. The old-zao gene module ...

－実験室での生命誕生過程の再現に向けて－ 理化学研究所（理研）生命機能科学研究センター高機能生体分子開発チームの李佩瑩（リ・ペエイ）研究員、田上俊輔チームリーダーらの国際共同研究チームは、正電荷を持つペプチド[1] 凝集体がRNA[2] を吸着し ...

DNA is the backbone of the genetic code so, logically, decoding and understanding the genetic sequence along with epigenetic modifications came first. Yet, RNA and the emerging field of ...

Korro Bio, Inc. (NASDAQ:KRRO), a biotechnology company specializing in RNA editing technology, stands at a critical juncture in its development. The firm’s innovative approach to treating genetic ...

Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company specializing in RNA editing oligonucleotides, is navigating a complex landscape of genetic medicine development. With an InvestingPro ...

Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity ...